Emerging Infectious Diseases (Sep 2023)
Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France
Abstract
Cefiderocol resistance is increasingly reported in New Delhi metallo-β-lactamase–producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued genomic surveillance of carbapenem-resistant Enterobacterales could clarify prevalence of cefiderocol-resistant E. coli in Europe.
Keywords